The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms

被引:14
作者
Fogel, S [1 ]
Riou, G [1 ]
机构
[1] Inst Gustave Roussy, Lab Pharmacol Clin & Mol, F-94800 Villejuif, France
关键词
D O I
10.1006/viro.1998.9086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cervical carcinoma-associated human papillomavirus type 16 (HPV16) encodes E6 and E7 oncoproteins which inactivate p53 and Rb, respectively, but these interactions are not sufficient to account for the oncogenic potential of the virus. Several viral promoters were shown to be regulated by E6 and E7. To identify genes as cellular targets of the HPV1G early proteins, we transfected a new HPV-negative and p53-mutated cervical carcinoma-derived cell line with either the HPV1G full-length genome or the HPV16 E6 gene. HPV1G clones but not 16E6 clones showed a decreased doubling time that was not related to the viral DNA and mRNA patterns. In exponentially growing cells as well as in cells synchronized by serum starvation, expression of the E6 gene was associated with upregulation of the c-fos and c-jun proto-oncogenes and with downregulation of the c-Ha-ras gene. Furthermore, a viral gene other than E6 may be involved in downregulation of p53 because a reduced mRNA level at the G1/S transition was observed only in HPV16-cells. The present study on natural host cells indicates p53-independent transcriptional modulations of cell cycle regulatory genes related to HPV1G E6 and E7 expression. (C) 1998 Academic Press.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 72 条
  • [31] KEEN N, 1994, ONCOGENE, V9, P1493
  • [32] CELL-SPECIFIC REGULATION OF THE C-MYC-GENE BY LYMPHOCYTE MITOGENS AND PLATELET-DERIVED GROWTH-FACTOR
    KELLY, K
    COCHRAN, BH
    STILES, CD
    LEDER, P
    [J]. CELL, 1983, 35 (03) : 603 - 610
  • [33] HUMAN PAPILLOMAVIRUS-16 E6 EXPRESSION DISRUPTS THE P53-MEDIATED CELLULAR-RESPONSE TO DNA DAMAGE
    KESSIS, TD
    SLEBOS, RJ
    NELSON, WG
    KASTAN, MB
    PLUNKETT, BS
    HAN, SM
    LORINCZ, AT
    HEDRICK, L
    CHO, KR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3988 - 3992
  • [34] Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein
    Kinoshita, T
    Shirasawa, H
    Shino, Y
    Moriya, H
    Desbarats, L
    Eilers, M
    Simizu, B
    [J]. VIROLOGY, 1997, 232 (01) : 53 - 61
  • [35] REPRESSION OF THE BASAL C-FOS PROMOTER BY WILD-TYPE P53
    KLEY, N
    CHUNG, RY
    FAY, S
    LOEFFLER, JP
    SEIZINGER, BR
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (15) : 4083 - 4087
  • [36] Telomerase activation by the E6 gene product of human papillomavirus type 16
    Klingelhutz, AJ
    Foster, SA
    McDougall, JK
    [J]. NATURE, 1996, 380 (6569) : 79 - 82
  • [37] CANCER - P53, GUARDIAN OF THE GENOME
    LANE, DP
    [J]. NATURE, 1992, 358 (6381) : 15 - 16
  • [38] HUMAN PAPILLOMAVIRUS E6 PROTEINS BIND P53 INVIVO AND ABROGATE P53-MEDIATED REPRESSION OF TRANSCRIPTION
    LECHNER, MS
    MACK, DH
    FINICLE, AB
    CROOK, T
    VOUSDEN, KH
    LAIMINS, LA
    [J]. EMBO JOURNAL, 1992, 11 (08) : 3045 - 3052
  • [39] Repression of p53 transcriptional activity by the HPV E7 proteins
    Massimi, P
    Banks, L
    [J]. VIROLOGY, 1997, 227 (01) : 255 - 259
  • [40] TRANSFORMATION OF PRIMARY HUMAN FIBROBLAST CELLS WITH HUMAN PAPILLOMAVIRUS TYPE-16 DNA AND EJ-RAS
    MATLASHEWSKI, G
    OSBORN, K
    BANKS, L
    STANLEY, M
    CRAWFORD, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (02) : 232 - 238